Literature DB >> 16935899

The relationship between estimated glomerular filtration rate, demographic and anthropometric variables is mediated by muscle mass in non-diabetic patients with chronic kidney disease.

Jamie Hugo Macdonald1, Samuele Maria Marcora, Mick John Kumwenda, Mahdi Jibani, Gareth Roberts, Ruth Glover, Jeffrey Barron, Andrew Bruce Lemmey.   

Abstract

BACKGROUND: In this study (the first of two related papers), we report whether the relationship between the demographic and anthropometric variables (DA, i.e. age, gender, height and weight) employed in current creatinin (Cr)-based glomerular filtration rate (GFR) estimation equations and actual GFR is mediated by muscle mass.
METHODS: We studied 77 patients (mean age +/- SD, 65.1 +/- 11.9 years) with chronic kidney disease (mean GFR 45.7 +/- 28.6 ml/min/1.73 m2). Actual GFR was measured by the renal clearance of inulin (GFR(inu)). Appendicular lean mass (ALM) and its index (ALMI) by dual energy X-ray absorptiometry provided markers of muscle mass. Multiple regression analyses identified variables explaining variance in (i) GFR, (ii) ALM and (iii) Cr.
RESULTS: (i) The DA variables used in the abbreviated modification of diet in renal disease (MDRD) equation accounted for only 59.6% (P < 0.001) of the variance in GFR(inu), whilst adding ALMI explained an additional 10.4% variance (P < 0.001). If ALMI was entered first, the relationship between DA variables and GFR(inu) was reduced (for weight) or completely abolished (for age, gender and height). (ii) After inputting all the commonly used DA variables, 17.2% of the variance in ALM was unexplained. (iii) All the DA variables explained only 60.6% (P < 0.001) of the variance in Cr, whilst adding ALM explained an additional 4.2% variance (P < 0.005).
CONCLUSIONS: Muscle mass explained more variance in GFR(inu) than MDRD DA variables and mediated the relationship between GFR(inu) and DA variables. Furthermore, DA variables failed to account for individual differences in muscle mass or Cr. Consequently, there is a need to validate simpler, clinically obtainable measures of muscle mass and determine whether these measures will improve GFR estimation.

Entities:  

Mesh:

Year:  2006        PMID: 16935899     DOI: 10.1093/ndt/gfl430

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease.

Authors:  James B Wetmore; Robyn A Honea; Eric D Vidoni; Ammar Almehmi; Jeffrey M Burns
Journal:  Nephrol Dial Transplant       Date:  2010-11-23       Impact factor: 5.992

2.  Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

Authors:  A L Mindikoglu; J P Raufman; S L Seliger; C D Howell; L S Magder
Journal:  Transplant Proc       Date:  2011-09       Impact factor: 1.066

3.  Renal function equations before and after living kidney donation: a within-individual comparison of performance at different levels of renal function.

Authors:  Hilde Tent; Mieneke Rook; Lesley A Stevens; Willem J van Son; L Joost van Pelt; H Sijbrand Hofker; Rutger J Ploeg; Jaap J Homan van der Heide; Gerjan Navis
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

4.  Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis.

Authors:  Carl P Walther; Caitlin Wise Carter; Chai L Low; Peter Williams; Dena E Rifkin; Robert W Steiner; Joachim H Ix
Journal:  Nephrol Dial Transplant       Date:  2011-07-20       Impact factor: 5.992

5.  Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure.

Authors:  Katja Cvan Trobec; Mojca Kerec Kos; Stephan von Haehling; Stefan D Anker; Iain C Macdougall; Piotr Ponikowski; Mitja Lainscak
Journal:  Croat Med J       Date:  2015-12       Impact factor: 1.351

6.  Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.

Authors:  Adrien Flahault; Marie Metzger; Jean-François Chassé; Jean-Philippe Haymann; Jean-Jacques Boffa; Martin Flamant; François Vrtovsnik; Pascal Houillier; Bénédicte Stengel; Eric Thervet; Nicolas Pallet
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

7.  Development of a mortality score to assess risk of adverse drug reactions among hospitalized patients with moderate to severe chronic kidney disease.

Authors:  Monica Danial; Mohamed Azmi Hassali; Ong Loke Meng; Yoon Chee Kin; Amer Hayat Khan
Journal:  BMC Pharmacol Toxicol       Date:  2019-07-08       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.